Is psoriasis a bowel disease? Successful treatment with bile acids and bioflavonoids suggests it is

17 Apr.,2023

 

    • Skinner Jr., R.B.
    • Rosenberg E.W.
    • Noah P.W.

    Antimicrobial treatment of psoriasis.

    Dermatol Clin.

    1

    :

    909-913

    View in Article
    • Google Scholar
    • Hall R.P.
    • Gerber L.H.
    • Lawley T.J.

    IgA-containing immune complexes in patients with psoriatic arthritis.

    Clin Exp Rheumatol.

    2

    :

    221-225

    View in Article
    • PubMed
    • Google Scholar
    • Lindholm L.
    • Mobacken H.
    • Magnusson B.L.

    Circulating immune complexes in untreated psoriasis: a comparison of Raji-cell radioimmunoassay and polymorphonuclear leukocyte phagocytosis.

    Arch Dermatol Res.

    279

    :

    435-438

    View in Article
    • Scopus (2)
    • PubMed
    • Crossref
    • Google Scholar
    • Sarhan S.
    • Knodgen B.
    • Seiler N.

    The gastrointestinal tract as polyamine source for tumor growth.

    Anticancer Res.

    9

    :

    215-223

    View in Article
    • PubMed
    • Google Scholar
    • Uemura T.
    • Stringer D.E.
    • Blohm-Mangone K.A.
    • et al.

    Polyamine transport is mediated by both endocytic and solute carrier transport mechanisms in the gastrointestinal tract.

    Am J Physiol Gastrointest Liver Physiol.

    299

    :

    G517-G522

    View in Article
    • Scopus (60)
    • PubMed
    • Crossref
    • Google Scholar
    • Proctor M.S.
    • Wilkenson D.I.
    • Orenberg E.K.
    • et al.

    Lowered cutaneous and urinary levels of polyamines with clinical improvement in treated psoriasis.

    Arch Dermatol.

    115

    :

    945-949

    View in Article
    • Scopus (29)
    • PubMed
    • Crossref
    • Google Scholar
    • Pennycook G.
    • Cheyne J.A.
    • Barr N.
    • et al.

    On the reception and detection of pseudo-profound bullshit.

    Judgm Decis Mak.

    10

    :

    549-563

    View in Article
    • Google Scholar
    • Ely P.H.

    Pathogenesis of the bowel bypass syndrome (review).

    in:

    Dobson R.L. Thiers B.

    Pathogenesis of Skin Disease.

    Churchill Livingston

    ,

    New York, NY

    :

    281-305

    View in Article
    • Google Scholar
    • Ely P.H.

    Immunopathology of the bowel bypass syndrome.

    in:

    MacDonald D.M.

    Immunodermatology.

    Butterworth

    ,

    London

    :

    287-289

    View in Article
    • Crossref
    • Google Scholar
    • Ghanim H.
    • Sia C.L.
    • Upadhyay M.
    • et al.

    Orange juice neutralizes the proinflammatory effect of a high-fat, high carbohydrate meal and prevents endotoxin increase and Toll-like receptor expression 1,2,3.

    Am J Clin Nutr.

    91

    :

    940-949

    View in Article
    • Scopus (248)
    • PubMed
    • Crossref
    • Google Scholar
    • Karlsson F.H.
    • Fak F.
    • Nookaew I.
    • et al.

    Symptomatic atherosclerosis is associated with an altered gut metagenome.

    Nat Commun.

    3

    :

    1-8

    View in Article
    • Scopus (794)
    • Crossref
    • Google Scholar
    • Oude Nijhuis M.M.

    Peptidoglycan in atherosclerotic plaque formation and vulnerability.

    Utrecht University Repository

    ,

    :

    1-172

    View in Article
    • Google Scholar
    • Kozarov E.V.
    • Dorn B.R.
    • Shelburne C.E.
    • et al.

    Human atherosclerotic plaque contains viable invasive Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis.

    Arterioscler Thromb Vasc Biol.

    25

    :

    e17-e18

    View in Article
    • PubMed
    • Crossref
    • Google Scholar
    • Human Microbiome Project Consortium

    Structure function and diversity of the healthy human microbiome: a detailed catalogue of the human gut microbiome.

    Nature.

    486

    :

    207-214

    View in Article
    • Scopus (7040)
    • PubMed
    • Crossref
    • Google Scholar
    • Yang X.
    • Xie L.
    • Li Y.
    • et al.

    More than 9,000,000 unique genes in human gut bacterial community; estimating gene numbers inside a human body.

    PLoS One.

    4

    e6074View in Article
    • Scopus (109)
    • PubMed
    • Crossref
    • Google Scholar
    • Proal A.D.
    • Albert P.J.
    • Marshall T.G.

    Inflammatory disease and the human microbiome.

    Discov Med.

    17

    :

    257-265

    View in Article
    • PubMed
    • Google Scholar
    • Penner E.
    • Albini B.
    • Milgrom F.

    Detection of circulating immune complexes in alcoholic liver disease.

    Clin Exp Immunol.

    34

    :

    28-31

    View in Article
    • PubMed
    • Google Scholar
    • Kunitake A.

    A study of endotoxemia in ulcerative colitis and Crohn’s disease. I Clinical study.

    Acta Med Okayama.

    32

    :

    147-158

    View in Article
    • PubMed
    • Google Scholar
    • Alekseyenko A.V.
    • Perez-Perez G.I.
    • De Souza A.
    • et al.

    Community differentiation of the cutaneous microbiota in psoriasis.

    Microbiome.

    1

    :

    31

    View in Article
    • PubMed
    • Crossref
    • Google Scholar
    • Scher J.U.
    • Ubeda C.
    • Artacho A.
    • et al.

    Decreased bacterial diversity characterizes the altered gut microbiota in patients with psoriatic arthritis, resembling dysbiosis in inflammatory bowel disease.

    Arthritis Rheumatol.

    67

    :

    128-139

    View in Article
    • Scopus (485)
    • PubMed
    • Crossref
    • Google Scholar
    • Eppinga H.
    • Sperna Weillan C.J.
    • Thio H.B.
    • et al.

    Similar depletion of protective Faecalibacterium prausnitzii in psoriasis and inflammatory bowel disease, but not in hidradenitis suppurativa.

    J Crohns Colitis.

    10

    :

    1067-1075

    View in Article
    • Scopus (112)
    • PubMed
    • Crossref
    • Google Scholar
    • Peslyak M.

    Model of pathogenesis of psoriasis part 1.

    in: Systemic psoriatic process. edition e4.0. ( )View in Article
    • Google Scholar
    • Peslyak M.

    Model of pathogenesis of psoriasis part 2.

    in: Systemic psoriatic process. edition e4.0. ( )View in Article
    • Google Scholar
    • Gumayunova N.G.

    Syndrome of small intestine bacterial overgrowth at psoriatic disease against blastocystic invasion.

    Dissertation

    ,

    Chelyabinsk

    View in Article
    • Google Scholar
    • Gumayunova N.G.
    • Potaturkana-Nesterova N.I.
    • Nesterov A.S.
    • et al.

    New approaches to diagnosis of intestinal dysbiosis of patients who have psoriatic disease.

    Bull Russ Peoples Friendship Univ Med.

    :

    93-97

    View in Article
    • Google Scholar
    • Gumayunova N.G.

    Revealing of small intestine bacterial overgrowth at psoriatic diseases.

    Postgrad Bull Volga Region.

    :

    162-164

    View in Article
    • Google Scholar
    • Pavlenok N.V.
    • Mahnovets E.N.

    Features of the clinical picture of psoriasis vulgaris in chronic H. pylori infection.

    Bull N Med Technol.

    :

    106-107

    View in Article
    • Google Scholar
    • Mccoll K.E.L.
    • El-Omar E.

    Mechanisms involved in the development of hypochlorhydria and pangastritis in Helicobacter pylori infection.

    in:

    Hunt R.H. Tytgat G.N.J.

    Helicobacter Pylori.

    Springer

    ,

    The Netherlands

    :

    373-384

    View in Article
    • Crossref
    • Google Scholar
    • Hartman P.
    • Chen W.C.
    • Schnabl B.

    The intestinal microbiome and the leaky gut as therapeutic targets in alcoholic liver disease.

    Front Physiol.

    3

    :

    402

    View in Article
    • Scopus (81)
    • PubMed
    • Crossref
    • Google Scholar
    • Gabbard S.L.
    • Lacy B.E.
    • Levine G.M.
    • et al.

    The impact of alcohol consumption and cholecystectomy on small intestinal bacterial overgrowth.

    Dig Dis Sci.

    59

    :

    638-644

    View in Article
    • Scopus (60)
    • PubMed
    • Crossref
    • Google Scholar
    • Bull-Otterson L.
    • Feng W.
    • Kirpich I.
    • et al.

    Metagenomic analyses of alcohol induced pathogenic alterations in the intestinal microbiome and the effect of Lactobacillus rhamnosus CG treatment.

    PLoS One.

    8

    e53028View in Article
    • Scopus (364)
    • PubMed
    • Crossref
    • Google Scholar
    • Zhong W.
    • Zhou Z.

    Alterations of the gut microbiome and metabolome in alcoholic liver disease.

    World J Gastrointest Pathophysiol.

    5

    :

    514-522

    View in Article
    • PubMed
    • Crossref
    • Google Scholar
    • Madrid A.M.
    • Hurtado C.
    • Venegas M.
    • et al.

    Long-term treatment with cisapride and antibiotics in liver cirrhosis: effect on small intestinal motility, bacterial overgrowth, and liver function.

    Am J Gastroenterol.

    96

    :

    1251-1255

    View in Article
    • PubMed
    • Crossref
    • Google Scholar
    • Flemins S.
    • Toratani S.
    • Shea-Donahue T.
    • et al.

    Pro- and anti-inflammatory gene expression in the murine small intestine and liver after chronic exposure to alcohol.

    Alcohol Clin Exp Res.

    25

    :

    579-589

    View in Article
    • Scopus (70)
    • PubMed
    • Crossref
    • Google Scholar
    • Nanji A.A.
    • Khettry U.
    • Sadrzadeh S.M.
    • et al.

    Severity of liver injury in experimental liver disease. Correlation with plasma endotoxin, prostaglandin E2, leukotriene B4, and thromboxane B2.

    Am J Pathol.

    142

    :

    367-373

    View in Article
    • PubMed
    • Google Scholar
    • Boursier J.
    • Mueller O.
    • Barret M.
    • et al.

    The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota.

    Hepatology.

    63

    :

    764-775

    View in Article
    • Scopus (755)
    • PubMed
    • Crossref
    • Google Scholar
    • Kelesidis T.
    • Pothoulakis C.

    Efficacy and safety of the probiotic Saccharomyces boulardii for the prevention and therapy of gastrointestinal disorders.

    Ther Adv Gastroenterol.

    5

    :

    111-125

    View in Article
    • Scopus (203)
    • PubMed
    • Crossref
    • Google Scholar
    • Kocsár L.T.
    • Bertók L.
    • Várterész V.

    Function of bile acids in the intestinal absorption of endotoxin in rats.

    Ann Immunol Hung.

    17

    :

    49-52

    View in Article
    • PubMed
    • Google Scholar
    • Ding J.W.
    • Andersson R.
    • Soltesz V.
    • et al.

    The role of bile and bile acids in bacterial translocation in obstructive jaundice in rats.

    Eur Surg Res.

    25

    :

    11-19

    View in Article
    • Scopus (116)
    • PubMed
    • Crossref
    • Google Scholar
    • Deopurkar R.
    • Ghanim H.
    • Friedman J.
    • et al.

    Differential effects of cream, glucose, and orange juice on inflammation, endotoxin, and the expression of toll-like receptor-4 and suppressor of cytokine signaling-3.

    Diabetes Care.

    33

    :

    991-997

    View in Article
    • Scopus (204)
    • PubMed
    • Crossref
    • Google Scholar
    • Egert S.
    • Bosy-Westphal A.
    • Seiberl J.
    • et al.

    Quercetin reduces systolic blood pressure and plasma oxidised low-density lipoprotein concentrations in overweight subjects with a high-cardiovascular disease risk phenotype: a double-blinded, placebo-controlled cross-over study.

    Br J Nutr.

    102

    :

    1065-1074

    View in Article
    • Scopus (417)
    • PubMed
    • Crossref
    • Google Scholar
    • Chan A.L.
    • Huang H.L.
    • Chien H.C.
    • et al.

    Inhibitory effects of quercetin derivatives on phosphodiesterase isozymes and high-affinity [(3) H]-rolipram binding in guinea pig tissues.

    Investig New Drugs.

    26

    :

    417-424

    View in Article
    • Scopus (24)
    • PubMed
    • Crossref
    • Google Scholar
    • Ko W.C.
    • Shih C.M.
    • Lai Y.H.
    • et al.

    Inhibitory effects of flavonoids on phosphodiesterase isozymes from guinea pig and their structure–activity relationships.

    Biochem Pharmacol.

    68

    :

    2087-2094

    View in Article
    • Scopus (133)
    • PubMed
    • Crossref
    • Google Scholar
    • Johansen C.
    • Funding A.T.
    • Otkjaer K.
    • et al.

    Protein expression of TNF-α in psoriatic skin is regulated at a posttranscriptional level by MAPK-activated protein kinase 2.

    J Immunol.

    176

    :

    1431-1438

    View in Article
    • Scopus (121)
    • PubMed
    • Crossref
    • Google Scholar
    • Vlahos C.J.
    • Matter W.F.
    • Hui K.Y.
    • et al.

    A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002).

    J Biol Chem.

    18

    :

    5241-5248

    View in Article
    • Google Scholar
    • Lee L.T.
    • Huang Y.T.
    • Hwang J.J.
    • et al.

    Blockade of the epidermal growth factor receptor tyrosine kinase activity by quercetin and luteolin leads to growth inhibition and apoptosis of pancreatic tumor cells.

    Anticancer Res.

    22

    :

    1615-1627

    View in Article
    • PubMed
    • Google Scholar
    • Heng M.C.Y.
    • Song M.K.
    • Heng M.K.

    Elevated phosphorylase kinase activity in psoriatic epidermis: correlation with increased phosphorylation and psoriatic activity.

    Br J Dermatol.

    130

    :

    298-306

    View in Article
    • Scopus (10)
    • PubMed
    • Crossref
    • Google Scholar
    • Heng M.C.Y.
    • Song M.K.
    • Harker J.

    Drug-induced suppression of phosphorylase kinase activity correlates with resolution of psoriasis as assessed by clinical, histological and immunohistochemical parameters.

    Br J Dermatol.

    143

    :

    937-949

    View in Article
    • Scopus (147)
    • PubMed
    • Crossref
    • Google Scholar
    • Ireson C.R.
    • Jones J.L.
    • Orr S.
    • et al.

    Metabolism of the cancer chemopreventive agent curcumin in human and rat intestine.

    Cancer Epidemiol Biomarkers Prev.

    11

    :

    105-111

    View in Article
    • PubMed
    • Google Scholar
    • Antiga E.
    • Bonciolini V.
    • Volpi W.
    • et al.

    Oral curcumin (meriva) is effective as an adjuvant treatment and is able to reduce IL-22 serum levels in patients with psoriasis vulgaris.

    BioMed Res Int.

    283634View in Article
    • PubMed
    • Google Scholar
    • Ghosh A.
    • Ghosh T.
    • Jain S.

    Silymarin—a review on the pharmacodynamics and bioavailability enhancement approaches.

    J Pharm Sci Technol.

    2

    :

    348-355

    View in Article
    • Google Scholar
    • El Menshawe S.F.
    • Ahmed A.S.
    • Abdelaty L.N.
    • et al.

    Study of hepatoprotective effect of silymarin and ursodeoxycholic acid in chronic hepatitis C patients.

    Med Sci.

    3

    :

    1655-1674

    View in Article
    • Crossref
    • Google Scholar
    • Tanoglu A.
    • Savasci U.
    • Karagoz E.

    May ursodeoxycholic acid significantly improve liver function tests among patients with hepatitis C.

    Med Sci.

    4

    :

    2986-2988

    View in Article
    • Crossref
    • Google Scholar
    • Giloteaux L.
    • Goodrich J.K.
    • Walters W.A.
    • et al.

    Reduced diversity and altered composition of the gut microbiome in individuals with myalgic encephalomyelitis/chronic fatigue syndrome.

    Microbiome.

    23

    :

    30

    View in Article
    • Scopus (189)
    • Crossref
    • Google Scholar

If you have any questions on tributyrin 1000 mg. We will give the professional answers to your questions.